Business Context and Reporting Period
Company: Curis, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 27, 2026
Reporting Period: Event-based report regarding Nasdaq listing status.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The only financial metric disclosed is the stock price performance triggering the listing review:
- Bid Price: Closed below the minimum $1.00 per share requirement for the last 30 consecutive business days.
Material Changes
The Company received a Delist Determination Letter from the Nasdaq Listing Qualifications Department on April 27, 2026. This action follows a prior Discretionary Panel Monitor initiated on February 3, 2026, under Listing Rule 5815(d)(4)(A). Due to this prior monitoring status, the Company was not afforded a standard cure period or plan of compliance opportunity for this specific deficiency.
Outlook, Risks, and Contingencies
- Delisting Schedule: Securities are scheduled for delisting from the Nasdaq Capital Market and suspension of trading at the opening on May 6, 2026.
- Appeal Process: The Company intends to request a hearing before the Nasdaq Hearings Panel by May 4, 2026. A timely request will stay further delisting actions.
- Risks: There is no assurance that the appeal will be successful or that the Company will remain listed on Nasdaq.
- Forward-Looking Statements: The filing includes standard disclaimers regarding the uncertainty of the appeal outcome and future listing status.
Investor Verification Checklist
- Verify the current stock price and whether it has recovered above $1.00 per share.
- Confirm the filing date of the Company's appeal request with the Nasdaq Hearings Panel (deadline: May 4, 2026).
- Monitor trading status for suspension effective May 6, 2026, pending the outcome of the appeal.
- Review the Company's most recent Form 10-K for detailed financial health and risk factors not included in this 8-K.